We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Economic and political fallout from war distracts governments from health threats
Steve Barclay heightens tension ahead of party conference with attack on consultants earning £130,000 a year
Many doctors, nurses and other staff who enter professional training never join full-time workforce, Nuffield Trust finds
Report shows 300% increase in demand for GLP-1 weight loss and diabetes drugs
Biobank deadlock is a symptom of the UK’s ailing innovation sector
If you can, save early as costs are rising - by more than a fifth in the past five years
Cambridge-based CMR Surgical aims to break ‘near-monopoly’ held by US group Intuitive Surgical
Four days of industrial action includes co-ordinated walkout by consultants and junior medics
Unlike the vaccine race, there is limited funding to treat a condition that is often debilitating
Policymakers are failing to address the likelihood of another pandemic
Drug resistance is not just a problem with bacteria
Staff shortages and prospect of more doctors’ strikes continue to challenge health system
Lives of 2mn mothers and babies could be saved by 2030 with small innovations in care, says Gates Foundation
Finger-prick technology on mobile device can detect long Covid and Alzheimer’s
Weight-loss medication can boost global welfare, but should not replace healthy habits
Stark findings highlight need to increase research into causes and more effective treatment
Treatment whose rollout was delayed by pandemic will now be run by Swiss group Stallergenes Greer
An increasing number of younger people are suffering disabilities so bad they cannot do a job
9/11’s aftermath is an invaluable source for those studying newer shocks
US watchdog steps up scrutiny of prohibited medicines sold through internet retailer
US health insurer faced anti-privatisation protests and hospital integration proved tricky
Efforts to tackle bribery and fraud could have far-reaching impact on doctors, patients and multinational drugmakers
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest shake-up in decades
UAE-backed healthcare provider’s move is latest example of Gulf country’s global acquisition drive
International Edition
